BNEW Health

Digital Therapies are a category of technology solutions that use evidence-based software to prevent, manage or treat disease. These therapies are designed to support patients in managing diseases such as diabetes, asthma, cardiovascular disorders and other chronic conditions. In doing so, they seek not only to improve patients' quality of life, but also to optimize clinical outcomes and increase the efficiency of the healthcare system, reducing costs and improving personalized medical care.
However, despite their potential, DTxs face some challenges. Among the most important limitations are concerns about the privacy of patient data, as the management of sensitive medical information must comply with strict data protection regulations. In addition, in Europe there is still no unified regulatory framework or specific body to oversee and certify the use of these technologies, which hinders their large-scale implementation and adoption in public healthcare systems in various countries.

Danilo Balcárcel Business Manager / Strategic partnerships of the Consorcio DTx OPINNO HEALTHCARE

Carlos Escobar Cardiologist, coordinator of clinical cardiology and continuity of care with Primary Care, University Hospital La Paz/Coordinator of automation of the vascular risk process of the Community of Madrid/Scientific coordinator of the DTX consortium HOSPITAL LA PAZ / CONSORCIO DTx

Gemma Malla Digital Medicines Head Iberia Oftalmology BU Head Spain ANGELINI PHARMA

Hugo Martínez de Lahidalga Strategic Business Development TECNALIA

Patricia Ripoll President and Founder FUNDACIÓN VISIBLE